Athanasios Pagonis, Athanasios Chalkias, Georgios Mavrovounis, Konstantinos Tourlakopoulos, Konstantinos Marsitopoulos, Nikolaos Papagiannakis, Maria Kechagia, Eleni Makri, Vasiliki Tsolaki, Zoe Daniil, Konstantinos Gourgoulianis, Ioannis Pantazopoulos
BACKGROUND: Patients with COVID-19 can rapidly deteriorate and develop acute hypoxic respiratory failure. Prominent features of the disease include severe inflammation, endotheliitis, and thrombosis. OBJECTIVES: The aim of the study was to evaluate the diagnostic and prognostic effectiveness of ischemia modified albumin (ΙΜΑ) in a cohort of COVID-19 patients. METHODS: This prospective observational study included adults with SARS-CoV-2 infection confirmed by reverse transcription polymerase chain reaction test, who were hospitalized specifically for COVID-19...
March 22, 2024: Heart & Lung: the Journal of Critical Care